Foss, AM; Terris-Prestholt, F; Cox, AP; Heise, L; Meyer-Rath, G; Delany-Moretlwe, S; Mertenskoetter, T; Rees, H; Vickerman, P; Watts, CH; (2012) Model projections of the population-level impact, on HIV and herpes simplex virus type-2 (HSV-2), and cost-effectiveness of tenofovir gel, an antiretroviral microbicide. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/20873 Full text not available from this repository.

Vickerman, P; Devine, A; Foss, A; Delany-Moretlwe, S; Mayaud, P; Meyer-Rath, G; (2012) Could HSV-2 suppressive therapy using valacyclovir be a cost-effective strategy for reducing HIV disease progression and transmission among HIV-1 infected women in South Africa? [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/20895 Full text not available from this repository.

Devine, A; Meyer-Rath, G; Foss, A; Vickerman, P; Edwards, M; Bachmann, M; Mayaud, P; Delany-Moretlwe, S; (2009) Cost and cost effectiveness of Herpes simplex virus-type 2 (hsv-2) suppressive therapy in HIV-1 and HSV-2 infected women in Johannesburg, South Africa. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/5470 Full text not available from this repository.

Vickerman, P; Devine, A; Meyer-Rath, G; Foss, A; Delany-Moretlwe, S; Mayaud, P; (2009) Modelling the cost-effectiveness of HSV-2 suppressive therapy for reducing HIV progression and infectivity among HIV infected women in South Africa. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/5471 Full text not available from this repository.